These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9422443)

  • 21. Comparison of a needle-free high-pressure injection system with needle-tipped injection of intracavernosal alprostadil for erectile dysfunction.
    Harding LM; Adeniyi A; Everson R; Barker S; Ralph DJ; Baranowski AP
    Int J Impot Res; 2002 Dec; 14(6):498-501. PubMed ID: 12494285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracavernosal injection therapy. Does it still have a role in erectile dysfunction?
    Chew KK
    Aust Fam Physician; 2001 Jan; 30(1):43-6. PubMed ID: 11211711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracavernosal prostaglandin E1 self vs office injection therapy in patients with erectile dysfunction.
    El-Sakka AI
    Int J Impot Res; 2006; 18(2):180-5. PubMed ID: 16163370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate.
    Israilov S; Niv E; Livne PM; Shmueli J; Engelstein D; Segenreich E; Baniel J
    Int J Impot Res; 2002 Feb; 14(1):38-43. PubMed ID: 11896476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Logistic regression and survival analysis of 450 impotent patients treated with injection therapy: long-term dropout parameters.
    Vardi Y; Sprecher E; Gruenwald I
    J Urol; 2000 Feb; 163(2):467-70. PubMed ID: 10647656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracavernosal injection therapy and surgical therapy in diabetic patients with erectile dysfunction.
    Savoca G; Silvestre G; Belgrano E
    Diabetes Nutr Metab; 2002 Feb; 15(1):53-7. PubMed ID: 11942740
    [No Abstract]   [Full Text] [Related]  

  • 27. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis.
    Elhanbly S; Schoor R; Elmogy M; Ross L; Hegazy A; Niederberger C
    J Urol; 2002 Jan; 167(1):192-6. PubMed ID: 11743303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective evaluation of efficacy and compliance with a multistep treatment approach for erectile dysfunction in patients after non-nerve sparing radical prostatectomy.
    Gontero P; Fontana F; Zitella A; Montorsi F; Frea B
    BJU Int; 2005 Feb; 95(3):359-65. PubMed ID: 15679794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Topical therapy in erectile dysfunction].
    Floth A
    Wien Med Wochenschr; 2000; 150(1-2):14-7. PubMed ID: 10746290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Instruction for papaverine self-injection program.
    Kramer-Levien KJ; Nellans R; Ellis L
    AUAA J; 1987; 7(4):17-8. PubMed ID: 3649223
    [No Abstract]   [Full Text] [Related]  

  • 31. [Response to intracavernous administration of 3 different drugs in the same group of patients with erectile dysfunction].
    Ribé N; Rajmil O; Bassas L; Jurado C; Pomerol JM
    Arch Esp Urol; 2001 May; 54(4):355-9. PubMed ID: 11455770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experience in the management of erectile dysfunction using the intracavernosal self-injection of vasoactive drugs.
    Watters GR; Keogh EJ; Earle CM; Carati CJ; Wisniewski ZS; Tulloch AG; Lord DJ
    J Urol; 1988 Dec; 140(6):1417-9. PubMed ID: 3193507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New treatment options for erectile dysfunction. Pharmacologic and nonpharmacologic options].
    Sperling H; Lümmen G; Schneider T; Rübben H
    Herz; 2003 Jun; 28(4):314-24. PubMed ID: 12825147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical course of penile fibrosis in intracavernosal prostaglandin E1 injection therapy: a follow-up of 44 patients.
    Chew KK; Stuckey BG
    Int J Impot Res; 2003 Apr; 15(2):94-8. PubMed ID: 12789387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracavernosal injection therapy for impotence.
    Benson GS
    J Urol; 1987 Nov; 138(5):1262. PubMed ID: 3669185
    [No Abstract]   [Full Text] [Related]  

  • 36. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 37. [Erectile dysfunction: an educational program].
    Jiménez Mayorga IE; Soto Jiménez T
    Rev Enferm; 1999 Feb; 22(2):151-5. PubMed ID: 10446611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracavernous injection as an option for aging men with erectile dysfunction.
    Wespes E
    Aging Male; 2002 Sep; 5(3):177-80. PubMed ID: 12471778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of patients receiving injection therapy for erectile dysfunction.
    Sundaram CP; Thomas W; Pryor LE; Sidi AA; Billups K; Pryor JL
    Urology; 1997 Jun; 49(6):932-5. PubMed ID: 9187703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nocturnal penile tumescence activity unchanged after long-term intracavernous injection therapy.
    Maniam P; Seftel AD; Corty EW; Rutchik SD; Hampel N; Althof SE
    J Urol; 2001 Mar; 165(3):830-2; discussion 832-3. PubMed ID: 11176480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.